Inventor
Andrew Richard Hudson
Inventor
San Diego, CA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes22%
A61NElectrotherapy6%
C07CAcyclic or carbocyclic compounds6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,736,875Methods and compositions associated with the granulocyte colony-stimulating factor receptor202010,376,514Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-ones201910,111,859Methods and compositions associated with the granulocyte colony-stimulating factor receptor201810,105,367Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones201810,092,575Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds201810,040,759Substituted azetidinyl compounds as GlyT1 inhibitors20189,956,224Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones20189,708,334'Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors'20179,622,991'Hematopoietic growth factor mimetic small molecule compounds and their uses'20179,533,996'Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones'20179,499,562'Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds'20169,492,430'Methods and compositions associated with the granulocyte colony-stimulating factor receptor'20169,175,010'Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-ones'20159,144,557'Hematopoietic growth factor mimetic small molecule compounds and their uses'20158,680,150'Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to LIGAND PHARM INC (6)· patent assignee history
2014–2015Patents assigned to BASINGER JILLIAN (2)· patent assignee history
2014–2015Patents assigned to HUDSON ANDREW R (2)· patent assignee history
2014–2020Based in San Diego, CA, US· patent location history
2015–2019Patents assigned to DART NEUROSCIENCE CAYMAN LTD (5)· patent assignee history
2016–2017Patents assigned to DART NEUROSCIENCE (CAYMAN) LTD (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LIGAND PHARM INC | 6 | 2014–2020 |
| DART NEUROSCIENCE CAYMAN LTD | 5 | 2015–2019 |
| DART NEUROSCIENCE (CAYMAN) LTD | 3 | 2016–2017 |
| BASINGER JILLIAN | 2 | 2014–2015 |
| HUDSON ANDREW Rself | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 15 | 2014–2020 |